Identification of a regulatory pathway governing TRAF1 via an arthritis-associated non-coding variant
Qiang WangiD, Marta Martínez‐BonetiD, Taehyeung KimiD, Jeffrey A. SparksiD, Kazuyoshi IshigakiiD, Xiaoting CheniD, Marc SudmaniD, Vitor R. C. AguiariD, Sangwan SimiD, Marcos ChiñasiD, Darren Jianjhih ChiuiD, Alexandra WactoriD, Brian Wauford, Miranda C. MarioniD, María Gutiérrez‐ArcelusiD, John BowesiD, Stephen EyreiD, Ellen Berit NordaliD, Sampath PrahaladiD, Marite RyggiD, Vibeke VidemiD, Soumya RaychaudhuriiD, Matthew T. WeirauchiD, Carl D. LangefeldiD, Susan D. ThompsoniD, Peter Andrija NigroviciD
Abstract
TRAF1/C5 was among the first loci shown to confer risk for inflammatory arthritis in the absence of an associated coding variant, but its genetic mechanism remains undefined. Using ImmunoChip data from 3,939 juvenile idiopathic arthritis (JIA) patients and 14,412 controls, we identified 132 plausible common non-coding variants, reduced serially by SNP-seq, electrophoretic mobility shift, and luciferase studies to the single variant rs7034653 in the third intron of TRAF1. Genetically manipulated experimental cells and primary monocytes from genotyped donors establish that the risk G allele reduces binding of Fos-Related Antigen 2 (FRA2), resulting in reduced TRAF1 expression and enhanced TNF production. Conditioning on this variant eliminates attributable risk for rheumatoid arthritis, implicating a mechanism shared across the arthritis spectrum. These findings reveal that rs7034653, FRA2, and TRAF1 mediate a pathway through which a non-coding causal variant drives risk of inflammatory arthritis in children and adults.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 7
- FWCI
- 1.16
- Field percentile
- top 22%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Functional and Computational Interrogation of the Juvenile Idiopathic Arthritis Risk Loci Identifies Candidate Causal SNPs and Target Genes in CD4+ T cells
Kaiyu Jiang, Emma K. Haley, … James N. Jarvis·medRxiv·Dec 16, 2025
- A Systematic Strategy for Identifying Causal Single Nucleotide Polymorphisms and Their Target Genes on Juvenile Arthritis Risk Haplotypes
Kaiyu Jiang, Tao Liu, … James N. Jarvis·bioRxiv·Mar 7, 2022
- Investigation of Association Between microRNA Variants and Risk of Rheumatoid Arthritis
Irfan Ullah, Muhammad Haseeb Tariq, … Mohsin Nawaz·Archives of Clinical and Biomedical ResearchPeer-reviewed·Jan 1, 2023
- The Juvenile Idiopathic Arthritis (JIA) Susceptibility Locus, IL2RA, Includes An Intronic Enhancer That Is Attenuated By JIA-Associated Genetic Variants
James N. Jarvis, Kaiyu Jiang, … Tao Liu·bioRxiv·Feb 18, 2019
- Analysis of Chromatin Data Supports a Role For CD14+ Monocytes/Macrophages in Mediating Genetic Risk for Juvenile Idiopathic Arthritis
Elizabeth A. Crinzi, Emma K. Haley, … James N. Jarvis·Frontiers in ImmunologyPeer-reviewed·Sep 29, 2022
- Identification of causal genes and mechanisms by which genetic variation mediates juvenile idiopathic arthritis susceptibility using functional genomics and CRISPR-Cas9
Antonios Frantzeskos, Valeriya Malysheva, … Gisela Orozco·medRxiv·May 22, 2025